London, UK: SMi Group’s 10th Clinical Trial Logistics conference opens its doors next month to all network movers and shakers representing pharma and biotech as well as regulatory bodies.
The 2016 agenda has been tailored to reflect industry-specific challenges on increasingly complex clinical trial logistics.
In addition to hearing case studies on regulatory updates and issues within supply chain operations, this year’s event will feature three presentations from industry leaders.
Get GCP-ready with Karyopharm Therapeutics
The impending promulgation of the International Conference on Harmonization (ICH) Good Clinical Practice (GCP) guidance and addendum E6 (R2) seeks to reform the clinical trials industry. Amer Alghabban, vice president, GxP Quality Assurance, Compliance & Training, will give an overview of updates and proposed changes to the addendum and ideas on how to prepare for these regulatory changes.
Norgine and WE Pharma to advise on supply chain efficiency
Dawn Padfield, director of Pharmaceutical Development and Clinical Supply at Norgine, will explain how to ensure and maintain successful contractor relationships with a focus on implementing due diligence to find the best fit when choosing a vendor. WE Pharma will be exhibiting at the conference and can advise on various regional issues and due diligence for suppliers.
Implement a patient centric clinical supply strategy with Sanofi
Does your supply chain strategy incorporate regulatory updates and patient needs? Rocio Cuadrado, TSOM Leader for Clinical Supplies, looks at how you can plan a compliant strategy with a focus on patient shipments.
Other featured speakers include MHRA, GlaxoSmithKline, Daiichi Sankyo, Merck Sharp and Dohme, Takeda, Teva, IAG Cargo and Janssen.
The event takes place on 18-19 May at the Holiday Inn Kensington Forum, London.
Posted on April 22, 2016
by Edwin Kalischnig